Standout Papers
- Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases (2007)
- A Controlled Trial of a Human Papillomavirus Type 16 Vaccine (2002)
- Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males (2011)
- Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study (2015)
- Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection (2015)
Immediate Impact
7 by Nobel laureates 12 from Science/Nature 62 standout
Citing Papers
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Chronic kidney disease
2021 Standout
Works of Eliav Barr being referenced
Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study
2015 Standout
A Controlled Trial of a Human Papillomavirus Type 16 Vaccine
2002 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Eliav Barr | 6945 | 1769 | 2827 | 74 | 9.5k | |
| David W. Alling | 3369 | 947 | 762 | 121 | 8.4k | |
| Catherine de Martel | 4676 | 1053 | 3316 | 41 | 10.2k | |
| Howard D. Strickler | 3799 | 335 | 1939 | 224 | 8.3k | |
| Sven Almér | 3730 | 1744 | 2828 | 156 | 10.2k | |
| Mark D. Pescovitz | 3955 | 416 | 3341 | 189 | 11.3k | |
| Cladd E. Stevens | 9667 | 8311 | 1052 | 122 | 17.2k | |
| Stephen Shiboski | 2384 | 279 | 2057 | 81 | 7.4k | |
| K A Fleming | 2275 | 1829 | 1105 | 180 | 6.5k | |
| Jenny Heathcote | 9606 | 9697 | 1678 | 169 | 12.2k | |
| Claude Chastang | 1622 | 578 | 831 | 149 | 9.3k |
All Works
Loading papers...